9 Meters Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019	2018	2017 - 2014
Market Capitalization	0	16	250	129	20	60	Upgrade
Market Cap Growth	-87.12%	-93.48%	93.78%	545.94%	-66.81%	948.00%	Upgrade
Enterprise Value	-3	6	203	91	19	60	Upgrade
PE Ratio	-	-0.37	-6.80	-2.10	-0.74	-2.49	Upgrade
PB Ratio	-3.16	6.80	6.01	4.02	-2.08	-16.46	Upgrade
P/FCF Ratio	-0.54	-0.44	-8.48	-6.65	-1.11	-3.97	Upgrade
P/OCF Ratio	-0.54	-0.44	-8.49	-6.65	-1.11	-3.97	Upgrade
EV/EBITDA Ratio	-0.41	-0.15	-5.54	-1.59	-0.73	-3.31	Upgrade
EV/EBIT Ratio	-0.41	-0.15	-5.54	-1.59	-0.73	-3.31	Upgrade
EV/FCF Ratio	-0.47	-0.17	-6.90	-4.71	-1.03	-3.93	Upgrade
Debt / Equity Ratio	-0.81	8.19	0.00	0.01	-0.33	-1.42	Upgrade
Debt / EBITDA Ratio	-0.12	-0.48	0.00	0.00	-0.13	-0.29	Upgrade
Debt / FCF Ratio	-0.14	-0.53	0.00	-0.01	-0.18	-0.34	Upgrade
Quick Ratio	0.49	0.97	5.56	5.54	0.31	0.57	Upgrade
Current Ratio	0.59	1.08	5.91	5.68	0.35	0.63	Upgrade
Interest Coverage	-12.53	-15.41	-778.42	-14.20	-13.82	-2.93	Upgrade
Return on Equity (ROE)	-585.00%	-254.10%	-79.90%	-936.00%	1716.00%	-1204.00%	Upgrade
Return on Assets (ROA)	-159.50%	-119.90%	-69.10%	-346.30%	-255.60%	-245.40%	Upgrade
Return on Capital (ROIC)	3640.38%	-190.40%	-88.12%	-166.19%	377.69%	-1185.23%	Upgrade
Earnings Yield	-3200769.92%	-268.11%	-14.70%	-47.62%	-135.31%	-40.12%	Upgrade
FCF Yield	-2575695.85%	-228.17%	-11.79%	-15.03%	-89.94%	-25.21%	Upgrade
Buyback Yield / Dilution	-5.27%	-6.58%	-130.12%	-216.97%	-34.59%	-108.29%	Upgrade
Total Shareholder Return	-5.27%	-6.58%	-130.12%	-216.97%	-34.59%	-108.29%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).